Find Ivacaftor manufacturers, exporters & distributors on PharmaCompass

Kalydeco

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 12 USDMF, 2 EU WC, 12 NDC API, 17 Listed Suppliers, $ API Reference Price

25 API Suppliers
12 USDMF
2 EU WC
12 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 18 FDA Orange Book, 24 Europe, 20 Canada, 16 Australia, 1 Listed Dossiers

79 FDF Dossiers
18 FDA Orange Book
24 Europe
20 Canada
16 Australia
1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Bioplus Life Sciences, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 22 Kerry, 1 Lonza Capsugel, 12 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 32 Direct Compression, 25 Coating Systems & Additives, 21 Granulation, 16 Co-Processed Excipients, 16 Disintegrants & Superdisintegrants, 16 Lubricants & Glidants, 15 Taste Masking, 14 Thickeners and Stabilizers, 14 Controlled & Modified Release, 11 Chewable & Orodispersible Aids, 10 Parenteral, 9 Solubilizers, 8 Film Formers & Plasticizers, 6 Topical, 4 Emulsifying Agents, 3 API Stability Enhancers, 3 Coloring Agents, 2 Rheology Modifiers, 1 Vegetarian Capsules, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 171 NEWS #PharmaBuzz

media
6 DATA COMPILATION #PharmaFlow
171 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 21 Finished Drug Prices, 24 Annual Reports

globalSalesInformation
1 US Medicaid Prescriptions
21 Finished Drug Prices
24 Annual Reports

MARKET PLACE

6 APIs

marketPlace
6 APIs

PATENTS & EXCLUSIVITIES

396 US Patents, 54 US Exclusivities, 3 Health Canada Patents

patents
396 US Patents
54 US Exclusivities
3 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 11,241

MARKET PLACE

API

FDF

6INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

39DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

396

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

171

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

25,486,737

Annual Reports (USD Million)

39,603

Finished Drug Prices

176 RELATED EXCIPIENT COMPANIES

291EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 873054-44-5, Vx-770, Kalydeco, Ivacaftor (vx-770), N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide, Vx 770

Molecular Formula

C₂₄H₂₈N₂O₃

Molecular Weight

392.5 g/mol

InChI Key

PURKAOJPTOLRMP-UHFFFAOYSA-N

FDA UNII

1Y740ILL1Z

Ivacaftor (also known as Kalydeco or VX-770) is a drug used for the management of Cystic Fibrosis (CF). It is manufactured and distributed by Vertex Pharmaceuticals. It was approved by the Food and Drug Administration on January 31, 2012, and by Health Canada in late 2012. Ivacaftor is administered as a monotherapy and also administered in combination with other drugs for the management of CF. Cystic Fibrosis is an autosomal recessive disorder caused by one of several different mutations in the gene for the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, an ion channel involved in the transport of chloride and sodium ions across cell membranes. CFTR is active in epithelial cells of organs such as of the lungs, pancreas, liver, digestive system, and reproductive tract. Alterations in the CFTR gene result in altered production, misfolding, or function of the protein and consequently abnormal fluid and ion transport across cell membranes. As a result, CF patients produce thick, sticky mucus that clogs the ducts of organs where it is produced making patients more susceptible to complications such as infections, lung damage, pancreatic insufficiency, and malnutrition. Prior to the development of ivacaftor, management of CF primarily involved therapies for the control of infections, nutritional support, clearance of mucus, and management of symptoms rather than improvements in the underlying disease process or lung function (FEV1). Notably, ivacaftor was the first medication approved for the management of the underlying causes of CF (abnormalities in CFTR protein function) rather than control of symptoms.

Ivacaftor is a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator. The mechanism of action of ivacaftor is as a Chloride Channel Activation Potentiator, and Cytochrome P450 2C9 Inhibitor, and P-Glycoprotein Inhibitor, and Cytochrome P450 3A Inhibitor.

1 2D Structure

Ivacaftor

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide

2.1.2 InChI

InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)

2.1.3 InChI Key

PURKAOJPTOLRMP-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C

2.2 Other Identifiers

2.2.1 UNII

1Y740ILL1Z

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3-quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-

2. Kalydeco

3. N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

4. N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

5. Vx-770

2.3.2 Depositor-Supplied Synonyms

1. 873054-44-5

2. Vx-770

3. Kalydeco

4. Ivacaftor (vx-770)

5. N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

6. Vx 770

7. N-[2,4-bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide

8. Chebi:66901

9. N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1h-quinoline-3-carboxamide

10. 1y740ill1z

11. 1413431-05-6

12. 3-quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-

13. N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

14. Vx770

15. 3-quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-

16. Kalydeco (tn)

17. Ivacaftor [usan]

18. Ivacaftor [usan:inn]

19. Ivacaftorum

20. Unii-1y740ill1z

21. Ivacaftor D18

22. Vx7

23. Ivacaftor [inn]

24. Ivacaftor [mi]

25. Ivacaftor (usan/inn)

26. Vx-770 - Ivacaftor

27. Ivacaftor [vandf]

28. Ivacaftor [who-dd]

29. Mls006011119

30. Schembl351373

31. Gtpl4342

32. Ivacaftor [orange Book]

33. Vx-770, Ivacaftor, Kalydeco

34. Chembl2010601

35. Dtxsid00236281

36. Ex-a441

37. Orkambi Component Ivacaftor

38. Symkevi Component Ivacaftor

39. Bcpp000199

40. Hms3654e10

41. Hms3744k05

42. Trikafta Component Ivacaftor

43. Bcp19794

44. Bdbm50032693

45. Mfcd17171361

46. S1144

47. Zinc52509463

48. Ivacaftor Component Of Orkambi

49. Akos015994762

50. Akos032950001

51. Ivacaftor Component Of Trikafta

52. Bcp9000799

53. Ccg-268562

54. Cs-0497

55. Db08820

56. Ex-7211

57. Le-0002

58. Sb16815

59. Ncgc00242480-01

60. Ncgc00242480-03

61. Ac-28324

62. Hy-13017

63. Smr004702900

64. Ft-0696681

65. Sw219620-1

66. Ec-000.2478

67. A25626

68. D09916

69. Ab01565806_02

70. Q6095693

71. Ctp-656; Ctp-656; Ctp-656; D9-ivacaftor;vx-561

72. Cystic Fibrosis Transmembrane Conductance Regulator Potentiator

73. N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1h-quinoline-3-carboxamide

74. N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

75. N-(5-hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide

76. N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

77. 1134822-00-6

78. Ivacaftor;n-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;ivacaftor

2.4 Create Date

2007-07-23

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₈N₂O₃
Molecular Weight	392.5 g/mol
XLogP3	5.6
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	4
Exact Mass	392.20999276 g/mol
Monoisotopic Mass	392.20999276 g/mol
Topological Polar Surface Area	78.4 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	671
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Kalydeco
PubMed Health	Ivacaftor (By mouth)
Drug Classes	Respiratory Agent
Drug Label	The active ingredient in KALYDECO tablets is ivacaftor, which has the following chemical name: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide. Its molecular formula is C24H28N2O3 and its molecular weight is 392.49. Iva...
Active Ingredient	Ivacaftor
Dosage Form	Tablet
Route	Oral
Strength	150mg
Market Status	Prescription
Company	Vertex Pharms

2 of 2
Drug Name	Kalydeco
PubMed Health	Ivacaftor (By mouth)
Drug Classes	Respiratory Agent
Drug Label	The active ingredient in KALYDECO tablets is ivacaftor, which has the following chemical name: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide. Its molecular formula is C24H28N2O3 and its molecular weight is 392.49. Iva...
Active Ingredient	Ivacaftor
Dosage Form	Tablet
Route	Oral
Strength	150mg
Market Status	Prescription
Company	Vertex Pharms

4.2 Drug Indication

When used as monotherapy as the product Kalydeco, ivacaftor is indicated for the management of CF in patients age 2 years and older who have a mutation in the CFTR gene that is responsive to ivacaftor potentiation. Ivacaftor received expanded approval in May 2017 for the following 33 CFTR mutations: E56K, P67L, R74W, D110E, D110H, R117C, R117H, G178R, E193K, L206W, R347H, R352Q, A455E, S549N, S549R, G551D, G551S, D579G, S945L, S977F, F1052V, K1060T, A1067T, G1069R, R1070Q, R1070W, F1074L, D1152H, G1244E, S1251N, S1255P, D1270N, and G1349D. When used in combination with the drug [lumacaftor] as the product Orkambi, ivacaftor is indicated for the management of CF patients age 6 years and older who are shown to be homozygous for the F508del mutation in the CFTR gene. When used in combination with [tezacaftor] in the product Symdeko, it is used to manage CF in patients 12 years and older who have at least one mutation in the CFTR gene or patients aged 12 or older who are shown to be homozygous for the F508del mutation. When used in combination with tezacaftor and [elexacaftor] in the product Trikafta, it is indicated for the treatment of cystic fibrosis in patients 12 years of age and older who have at least one _F508del_ mutation in the CFTR gene.

FDA Label

Kalydeco tablets are indicated:

- As monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (CF) who have an R117H CFTR mutation or one of the following gating (class III) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R (see sections 4. 4 and 5. 1).

- In a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (CF) who are homozygous for the F508del mutation or who are heterozygous for the F508del mutation and have one of the following mutations in the CFTR gene: P67L, R117C, L206W, R352Q, A455E, D579G, 711+3AG, S945L, S977F, R1070W, D1152H, 2789+5GA, 3272 26AG, and 3849+10kbCT.

- In a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (CF) who have at least one F508del mutation in the CFTR gene (see section 5. 1).

Kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (CF) who have an R117H CFTR mutation or one of the following gating (class III) mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R (see sections 4. 4 and 5. 1).

5 Pharmacology and Biochemistry

5.1 Pharmacology

The use of Ivacaftor has been shown to both improve CF symptoms and modulate underlying disease pathology. This is achieved by potentiating the channel opening probability (or gating) of CFTR protein in patients with impaired gating mechanisms. This is in contrast to [DB09280], another CF medication, that functions by preventing misfolding of the CFTR protein and thereby results in increased processing and trafficking of mature protein to the cell surface. Results from clinical trials indicated that treatment with ivacaftor results in improved lung function, reduced chance of experiencing a pulmonary exacerbation, reduced sweat chloride, increased weight gain, and improvements in CF symptoms and quality of life. When combined with tezacaftor, significant improvements in lung function have been observed in clinical studies. Ivacaftor was not found to increase the QTc interval in a clinically significant manner. Although ivacaftor given alone has not shown any significant improvements in patients with the delta-F508 mutation, it has shown significant improvements (>10% increase in FEV1 from baseline) in lung function for the following mutations: E56K, P67L, R74W, D110E, D110H, R117C, R117H, G178R, E193K, L206W, R347H, R352Q, A455E, S549N, S549R, G551D, G551S, D579G, S945L, S977F, F1052V, K1060T, A1067T, G1069R, R1070Q, R1070W, F1074L, D1152H, G1244E, S1251N, S1255P, D1270N, and G1349. This list was expanded by the FDA in May 2017 from 10 to 33 to accommodate more rare mutations. It is important to note that this drug may cause an increase in liver transaminases (ALT, AST). Ensure to assess liver transaminases before the initiation of treatment, every 3 months during the first year of administration, followed by every year thereafter.

5.2 MeSH Pharmacological Classification

Chloride Channel Agonists

A class of drugs that stimulate chloride ion influx through cell membrane channels. (See all compounds classified as Chloride Channel Agonists.)

5.3 FDA Pharmacological Classification

5.3.1 Active Moiety

IVACAFTOR

5.3.2 FDA UNII

1Y740ILL1Z

5.3.3 Pharmacological Classes

Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Chloride Channel Activation Potentiators [MoA]

5.4 ATC Code

R07AX02

R07AX30

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

R - Respiratory system

R07 - Other respiratory system products

R07A - Other respiratory system products

R07AX - Other respiratory system products

R07AX02 - Ivacaftor

5.5 Absorption, Distribution and Excretion

Absorption

Ivacaftor is well absorbed in the gastrointestinal tract. Following administration of ivacaftor with fat-containing foods, peak plasma concentrations were reached at 4 hours (Tmax) with a maximum concentration (Cmax) of 768 ng/mL and AUC of 10600 ng * hr/mL. It is recommended that ivacaftor is taken with fat-containing foods as they increase absorption by approximately 2.5- to 4-fold.

Route of Elimination

After oral administration, ivacaftor is mainly eliminated in the feces after metabolic conversion and this elimination represents 87.8% of the dose. From the total eliminated dose, the metabolites M1 and M6 account for the majority of the eliminated dose, being 22% for M1 and 43% for M6. Ivacaftor shows negligible urinary excretion as the unchanged drug.

Volume of Distribution

After oral administration of 150 mg every 12 hours for 7 days to healthy volunteers in a fed state, the mean (SD) for apparent volume of distribution was 353 (122) L.

Clearance

The CL/F (SD) for the 150 mg dose was 17.3 (8.4) L/hr in healthy subjects.

5.6 Metabolism/Metabolites

Ivacaftor is extensively metabolized in humans. In vitro and clinical studies indicate that ivacaftor is primarily metabolized by CYP3A. From this metabolism, the major formed metabolites are M1 and M6. M1 is considered pharmacologically active even though it just presents approximately one-sixth the effect of the parent compound ivacaftor. On the other hand, M6 is not considered pharmacologically active as it represents less than one-fiftieth of the effect of the parent compound.

5.7 Biological Half-Life

In a clinical study, the apparent terminal half-life was approximately 12 hours following a single dose of ivacaftor. One source mentions the half-life ranges from 12 to 14 hours.

5.8 Mechanism of Action

A wide variety of CFTR mutations correlate to the Cystic Fibrosis phenotype and are associated with differing levels of disease severity. The most common mutation, affecting approximately 70% of patients with CF worldwide, is known as F508del-CFTR or delta-F508 (F508), in which a deletion in the amino acid phenylalanine at position 508 results in impaired production of the CFTR protein, thereby causing a significant reduction in the amount of ion transporter present on cell membranes. Ivacaftor as monotherapy has failed to show a benefit for patients with delta-F508 mutations, most likely due to an insufficient amount of protein available at the cell membrane for interaction and potentiation by the drug. The next most common mutation, G551D, affecting 4-5% of CF patients worldwide is characterized as a missense mutation, whereby there is sufficient amount of protein at the cell surface, but opening and closing mechanisms of the channel are altered. Ivacaftor is indicated for the management of CF in patients with this second type of mutation, as it binds to and potentiates the channel opening ability of CFTR proteins on the cell membrane. Ivacaftor exerts its effect by acting as a potentiator of the CFTR protein, an ion channel involved in the transport of chloride and sodium ions across cell membranes of the lungs, pancreas, and other organs. Alterations in the CFTR gene result in altered production, misfolding, or function of the protein and consequently abnormal fluid and ion transport across cell membranes. Ivacaftor improves CF symptoms and underlying disease pathology by potentiating the channel open probability (or gating) of CFTR protein in patients with impaired CFTR gating mechanisms. The overall level of ivacaftor-mediated CFTR chloride transport is dependent on the amount of CFTR protein at the cell surface and how responsive a particular mutant CFTR protein is to ivacaftor potentiation.

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Alembic Pharmaceuticals Ltd

India

Antibody Engineering

Not Confirmed

02

Ar Life Sciences Pvt Ltd

India

Antibody Engineering

Not Confirmed

03

Apitoria Pharma Private Ltd

India

Antibody Engineering

Not Confirmed

04

Apitoria Pharma Private Ltd

Antibody Engineering

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"IVACAFTOR","year":"2021","qtr":"Q1","strtotime":1614105000,"product":"IVACAFTOR - BULK DRUG","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TUTEUR S.A.C.I.F.I.A.","customerCountry":"ARGENTINA","quantity":"12.00","actualQuantity":"12","unit":"KGS","unitRateFc":"10582.5","totalValueFC":"125669.8","currency":"USD","unitRateINR":762467.08333333337,"date":"24-Feb-2021","totalValueINR":"9149605","totalValueInUsd":"125669.8","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8885393","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623090600,"product":"IVACAFTOR (GROUP-B )(TAX INV NO:19002152 42 DT:31.05.2021","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ALGIERS","customer":"BIOPHARM SPA","customerCountry":"ALGERIA","quantity":"5.61","actualQuantity":"5.61","unit":"KGS","unitRateFc":"25046.3","totalValueFC":"137652.3","currency":"USD","unitRateINR":1804585.4723707663,"date":"08-Jun-2021","totalValueINR":"10123724.5","totalValueInUsd":"137652.3","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"2286147","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ALGERIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630693800,"product":"IVACAFTOR","address":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"AUROBINDO PHARMA LIMITED","supplierCountry":"INDIA","foreign_port":"LARNACA","customer":"EPL EARTHLINE PHARMA ","customerCountry":"CYPRUS","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"15200","totalValueFC":"14872.9","currency":"USD","unitRateINR":1094000,"date":"04-Sep-2021","totalValueINR":"1094000","totalValueInUsd":"14872.9","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4367429","productDescription":"API","marketType":"REGULATED MARKET","country":"CYPRUS","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,, HYDERABAD\/ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635791400,"product":"IVACAFTOR","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"REYKJAVIK KEFLAVIK","customer":"CORIPHARMA EHF","customerCountry":"ICELAND","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"10500","totalValueFC":"10259","currency":"USD","unitRateINR":764000,"date":"02-Nov-2021","totalValueINR":"764000","totalValueInUsd":"10259","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5765938","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641321000,"product":"IVACAFTOR - BULK DRUG","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ULKAR HOLDING","customerCountry":"TURKEY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"17000","totalValueFC":"8484","currency":"USD","unitRateINR":1264000,"date":"05-Jan-2022","totalValueINR":"632000","totalValueInUsd":"8484","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7256221","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646073000,"product":"IVACAFTOR - BULK DRUG *ARN NO. AD2403210","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"MICROSULES ARGENTINA S.A","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"15000","totalValueFC":"7307.8","currency":"USD","unitRateINR":1114000,"date":"01-Mar-2022","totalValueINR":"557000","totalValueInUsd":"7307.8","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8613760","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646677800,"product":"IVACAFTOR","address":"ALEMBIC ROAD VADODARA Contact No: 919727727339","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"TO THE ORDER OF","customerCountry":"GERMANY","quantity":"0.02","actualQuantity":"0.015","unit":"KGS","unitRateFc":"200000","totalValueFC":"2886.4","currency":"USD","unitRateINR":14666666.666666668,"date":"08-Mar-2022","totalValueINR":"220000","totalValueInUsd":"2886.4","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8765332","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ALEMBIC ROAD VADODARA Contact No: 919727727339, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649097000,"product":"IVACAFTOR","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"AUROBINDO PHARMA LIMITED","supplierCountry":"INDIA","foreign_port":"MADRID","customer":"LICONSA S.A.","customerCountry":"SPAIN","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"15000","totalValueFC":"1365.2","currency":"USD","unitRateINR":1030000,"date":"05-Apr-2022","totalValueINR":"103000","totalValueInUsd":"1365.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9491505","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653676200,"product":"IVACAFTOR","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"REYKJAVIK KEFLAVIK","customer":"TO THE ORDER..","customerCountry":"ICELAND","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"8000","totalValueFC":"3881.7","currency":"USD","unitRateINR":600000,"date":"28-May-2022","totalValueINR":"300000","totalValueInUsd":"3881.7","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"1722092","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666204200,"product":"IVACAFTOR","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"AUROBINDO PHARMA LIMITED","supplierCountry":"INDIA","foreign_port":"LARNACA","customer":"EPL EARTHLINE PHARMA ","customerCountry":"CYPRUS","quantity":"8.16","actualQuantity":"8.16","unit":"KGS","unitRateFc":"10185","totalValueFC":"81388.6","currency":"USD","unitRateINR":820710.78431372542,"date":"20-Oct-2022","totalValueINR":"6697000","totalValueInUsd":"81388.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4965842","productDescription":"API","marketType":"REGULATED MARKET","country":"CYPRUS","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670956200,"product":"IVACAFTOR","address":"KALPATARU INSPIRE, 3RD FLOOR, OFF WESTERN EXPRESS HIGHWAY SANTACRUZ E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"SANOVEL ILAC SAN. ","customerCountry":"TURKEY","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"13000","totalValueFC":"582.5","currency":"USD","unitRateINR":960000,"date":"14-Dec-2022","totalValueINR":"48000","totalValueInUsd":"582.5","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"6132899","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"KALPATARU INSPIRE, 3RD FLOOR, OFF WESTERN EXPRESS HIGHWAY SANTACRUZ E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684434600,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS API EXPORT INVOICE NUMBER F32418000556 DT 16 05 2023 IVACAFTOR","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER","customerCountry":"GREECE","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"10000","totalValueFC":"1932.3","currency":"USD","unitRateINR":795000,"date":"19-May-2023","totalValueINR":"159000","totalValueInUsd":"1932.3","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684780200,"product":"MSN ACTIVE PHARMACEUTICAL PRODUCT AS PERATTACHED INVOICE NO 1900235139 IVACAFTOR","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"VILNIUS","customer":"TO THE ORDER","customerCountry":"LITHUANIA","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"12500","totalValueFC":"24.3","currency":"USD","unitRateINR":200000,"date":"23-May-2023","totalValueINR":"2000","totalValueInUsd":"24.3","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"LITHUANIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691951400,"product":"IVACAFTOR","address":"PLOT NO.2 MAITRIVIHARBEHIND MAI TRIVANAM AMEERPET","city":"Hyderabad","supplier":"AUROBINDO PHARMA LIMITED","supplierCountry":"INDIA","foreign_port":"NA","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"17435.9","totalValueFC":"4309.7","currency":"USD","unitRateINR":1427999.8824,"date":"14-Aug-2023","totalValueINR":"356999.9706","totalValueInUsd":"4309.7","indian_port":"HYDERABAD ICD","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"PLOT NO.2 MAITRIVIHARBEHIND MAI TRIVANAM AMEERPET, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697740200,"product":"IVACAFTOR","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"JOINT STOCK COMPANY ","customerCountry":"RUSSIA","quantity":"0.65","actualQuantity":"0.65","unit":"KGS","unitRateFc":"902000","totalValueFC":"6920.6","currency":"INR","unitRateINR":886153.84615384613,"date":"20-Oct-2023","totalValueINR":"576000","totalValueInUsd":"6920.6","indian_port":"Bangalore Air","hs_no":"29420013","bill_no":"4801422","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698431400,"product":"IVACAFTOR","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ALGIERS","customer":"TO THE ORDER OF","customerCountry":"ALGERIA","quantity":"9.00","actualQuantity":"9","unit":"KGS","unitRateFc":"25000","totalValueFC":"222794.1","currency":"USD","unitRateINR":2060333.3333333333,"date":"28-Oct-2023","totalValueINR":"18543000","totalValueInUsd":"222794.1","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4951946","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ALGERIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700677800,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS - (API) IVACAFTOR","address":"ALEMBIC ROAD","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"YELGRAD (BEOGRAD)","customer":"TO THE ORDER OF","customerCountry":"SERBIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"9500","totalValueFC":"13954.5","currency":"USD","unitRateINR":774666.66666666663,"date":"23-Nov-2023","totalValueINR":"1162000","totalValueInUsd":"13954.5","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"5526611","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SERBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"ALEMBIC ROAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704911400,"product":"IVACAFTOR","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"PHARMAPATH S.A","customerCountry":"GREECE","quantity":"36.00","actualQuantity":"36","unit":"KGS","unitRateFc":"6750","totalValueFC":"240831.2","currency":"USD","unitRateINR":555996.9444444445,"date":"11-Jan-2024","totalValueINR":"20015890","totalValueInUsd":"240831.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6694831","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"IVACAFTOR","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"SANOVEL ILAC SAN.VE TIC.A.S.,","customerCountry":"TURKEY","quantity":"0.15","actualQuantity":"0.15","unit":"KGS","unitRateFc":"15000","totalValueFC":"2162.8","currency":"USD","unitRateINR":1198386.6666666667,"date":"17-Jan-2024","totalValueINR":"179758","totalValueInUsd":"2162.8","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6813733","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708972200,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32418004694 DT. 16.02.2024 IVACAFTOR","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"N\/A","customer":"N\/A","customerCountry":"ICELAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"8000","totalValueFC":"79087.9","currency":"USD","unitRateINR":656222.09999999998,"date":"27-Feb-2024","totalValueINR":"6562221","totalValueInUsd":"79087.9","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"7884589","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709317800,"product":"IVACAFTOR","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"LARNACA","customer":"REMEDICA LTD","customerCountry":"CYPRUS","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"10000","totalValueFC":"19688.5","currency":"USD","unitRateINR":817423.92500000005,"date":"02-Mar-2024","totalValueINR":"1634847.85","totalValueInUsd":"19688.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"7998549","productDescription":"API","marketType":"REGULATED MARKET","country":"CYPRUS","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710268200,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32418004764 DT. 22.02.2024 IVACAFTOR","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER","customerCountry":"GREECE","quantity":"7.77","actualQuantity":"7.77","unit":"KGS","unitRateFc":"7000","totalValueFC":"53617.6","currency":"USD","unitRateINR":572995.81853281858,"date":"13-Mar-2024","totalValueINR":"4452177.51","totalValueInUsd":"53617.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8277229","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713465000,"product":"IVACAFTOR (RUB - 0.9058)","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"JSC PHARMASYNTEZ","customerCountry":"RUSSIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2271050","totalValueFC":"24425","currency":"RUB","unitRateINR":2039667.0900000001,"date":"19-Apr-2024","totalValueINR":"2039667.09","totalValueInUsd":"24425","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"9245289","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724092200,"product":"IVACAFTOR","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"LARNACA","customer":"REMEDICA LTD \\'A\\' LIMASSOL","customerCountry":"CYPRUS","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"11000","totalValueFC":"65214.7","currency":"USD","unitRateINR":911686.16666666663,"date":"20-Aug-2024","totalValueINR":"5470117","totalValueInUsd":"65214.7","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3322528","productDescription":"API","marketType":"REGULATED MARKET","country":"CYPRUS","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726425000,"product":"IVACAFTOR (AS PER INVOICE)","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ULKAR HOLDING","customerCountry":"TURKEY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"19800","totalValueFC":"9587.2","currency":"USD","unitRateINR":1606838.76,"date":"16-Sep-2024","totalValueINR":"803419.38","totalValueInUsd":"9587.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4043335","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726425000,"product":"IVACAFTOR PREMIX (AS PER INVOICE)","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ULKAR HOLDING","customerCountry":"TURKEY","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"18000","totalValueFC":"4357.8","currency":"USD","unitRateINR":1460762.52,"date":"16-Sep-2024","totalValueINR":"365190.63","totalValueInUsd":"4357.8","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4043335","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730399400,"product":"IVACAFTOR","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"ELPEN PHARMACEUTICAL","customerCountry":"GREECE","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"15000","totalValueFC":"656.4","currency":"USD","unitRateINR":1107840,"date":"01-Nov-2024","totalValueINR":"55392","totalValueInUsd":"656.4","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"5313552","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732732200,"product":"IVACAFTOR BATCH : IVCA-3-734-74","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"ZYDUS LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"GENEPHARM S.A","customerCountry":"GREECE","quantity":"0.03","actualQuantity":"33","unit":"GMS","unitRateFc":"11","totalValueFC":"341.6","currency":"USD","unitRateINR":873.62,"date":"28-Nov-2024","totalValueINR":"28829.46","totalValueInUsd":"341.6","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"5983455","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729621800,"product":"IVACAFTOR F-B IH (MSN) (IVACAFTOR)(FOR PHARMACEUTICAL USE ONLY)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"MYLAN LABORATORIES LIMITED FDF UNIT-3","supplierCountry":"INDIA","foreign_port":"NASIK","customer":"VIATRIS","customerCountry":"INDIA","quantity":"135.00","actualQuantity":"135","unit":"KGS","unitRateFc":"7","totalValueFC":"961.7","currency":"USD","unitRateINR":"598.6","date":"23-Oct-2024","totalValueINR":"80811","totalValueInUsd":"961.7","indian_port":"Indore-EPZ\/SEZ","hs_no":"29333990","bill_no":"6283338","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NASIK","supplierAddress":"Plot No 11,12 & 13, SEZ Phase II, ISEZ Sector 3, Pithampur, Dist Dhar SDNF India","customerAddress":"564\/A\/22, ROAD NO.92"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

01 Vertex Pharmaceuticals

U.S.A

U.S.A

Antibody Engineering

Not Confirmed

10 Vertex Pharmaceuticals

U.S.A

Antibody Engineering

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

01

Malladi Drugs & Pharmaceuticals Lim...

India

Antibody Engineering

Not Confirmed

Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

4-oxo-l ,4-dihydroquinoline -3-carboxylic acid

CAS Number : 13593-94-7

End Use API : Ivacaftor

02

Soujanya Life Sciences

India

Antibody Engineering

Not Confirmed

Soujanya Life Sciences makes API & intermediates for various therapeutic categories including Antidiabetic, Anti-Hypertensive, etc.

4-Oxo-1,4-dihydroquinoline-3-carboxylic

CAS Number : 13721-01-2

End Use API : Ivacaftor

Product Web Link

Corporate PDF

03

Hangzhou Longshine Bio-Tech Co.,LTD

China

Antibody Engineering

Not Confirmed

04

Hangzhou Longshine Bio-Tech Co.,LTD

China

Antibody Engineering

Not Confirmed

05

Vidgas Science & Technologies

India

Antibody Engineering

Not Confirmed

06

Vidgas Science & Technologies

India

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

01

Medichem S.A

Spain

Antibody Engineering

Not Confirmed

Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Contact Supplier

Spain

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Spain

Ivacaftor

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

02

Vertex Pharmaceuticals

U.S.A

Antibody Engineering

Not Confirmed

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Direct Compression

Coating Systems & Additives

Granulation

Co-Processed Excipients

Disintegrants & Superdisintegrants

Lubricants & Glidants

Taste Masking

Thickeners and Stabilizers

Controlled & Modified Release

Chewable & Orodispersible Aids

Parenteral

Solubilizers

Film Formers & Plasticizers

Topical

Emulsifying Agents

API Stability Enhancers

Coloring Agents

Rheology Modifiers

Vegetarian Capsules

Surfactant & Foaming Agents

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Ivacaftor API needed in India [ENA18204]

A company that focuses on the research and development of OSDs, oral liquids, injectables, ointments & creams is looking for suppliers of Ivacaftor API for development purposes. The suppliers must support this enquiry with CoA.

03 Oct 2023

Ivacaftor (1 kg) API needed in the United States [ENA14808]

A CDMO that focuses on the development, manufacturing and marketing of various pharmaceutical excipients, cosmetics & medical devices is looking for suppliers of Ivacaftor (1 kg) API for development purpose.

26 Aug 2022

Ivacaftor (200 mg) API needed in Australia [ENA08247]

One of the top universities in Australia is looking for suppliers of Ivacaftor (200 mg) API for research purposes on animals.

17 Aug 2020

USP/BP Grade Ivacaftor (250 g) API needed in India [ENA06421]

A pharmaceutical manufacturing and drug development company is looking for suppliers of USP/BP Grade Ivacaftor (250 g) API for formulation development. The supplier must support this enquiry with CoA.

29 Jan 2020

Ivacaftor, Lumacaftor and various other APIs needed in India [ENA04878]

A company manufacturing a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments is looking for various APIs mentioned below for developmental purposes: 1. Ivacaftor 2. Lumacaftor 3. Elexacaftor 4. Tezacaftor

12 Aug 2019

Lumacaftor and Ivacaftor APIs needed in Egypt [ENA03466]

One of the dominant players in the pharmaceutical industry in Egypt, the Middle East, and Africa is looking for suppliers of below APIs: 1. Lumacaftor | Spec: In-house (Microfine powder NLT 90% passes sieve #45) | R&D Qty: 200g | Pilot Batch Qty: 10kg | Commercial Qty: 100kg 2. Ivacaftor | Spec: In-house (Microfine powder NLT 90% passes sieve #45) | R&D Qty: 125g | Pilot Batch Qty: 7kg | Commercial Qty: 70kg

18 Feb 2019

IVACAFTOR; LUMACAFTOR

Antibody Engineering

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Post Enquiry

Market Place

Find Ivacaftor manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers

12 USDMF

2 EU WC

12 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

39 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers

18 FDA Orange Book

24 Europe

20 Canada

16 Australia

1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

13 SPI Pharma

4 DKSH

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

11 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

1 Bioplus Life Sciences

5 Corel Pharma Chem

5 DFE Pharma

1 Finar

8 Gangwal Chemicals

3 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

22 Kerry

1 Lonza Capsugel

12 Microlex e.U

2 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

13 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders

32 Direct Compression

25 Coating Systems & Additives

21 Granulation

16 Co-Processed Excipients

16 Disintegrants & Superdisintegrants

16 Lubricants & Glidants

15 Taste Masking

14 Thickeners and Stabilizers

14 Controlled & Modified Release

11 Chewable & Orodispersible Aids

10 Parenteral

9 Solubilizers

8 Film Formers & Plasticizers

6 Topical

4 Emulsifying Agents

3 API Stability Enhancers

3 Coloring Agents

2 Rheology Modifiers

1 Vegetarian Capsules

1 Surfactant & Foaming Agents